Elanco Animal Health Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015
Net Income	-1,231	-78	-483	-574	68	86.5	-310.7	-47.9	-210.8
Depreciation & Amortization	694	682	716	517	314	296	318.4	254.4	236.9
Share-Based Compensation	46	59	66	47	49	26	25	20.4	13.4
Other Operating Activities	762	-211	184	-31	-207	78.8	141.1	-71	-32.9
Operating Cash Flow	271	452	483	-41	224	487.3	173.8	155.9	6.6
Operating Cash Flow Growth	-40.04%	-6.42%	-	-	-54.03%	180.38%	11.48%	2262.12%	-
Capital Expenditures	-140	-171	-159	-239	-197	-127.1	-79.5	-102.9	-79.8
Acquisitions	-19	0	-342	-4,566	-33	0	-882.1	-45	-5,283.1
Other Investing Activities	-10	-8	-29	26	-5	0.1	-3	-34.2	367.5
Investing Cash Flow	-169	-179	-530	-4,779	-235	-127	-964.6	-182.1	-4,995.4
Share Issuance / Repurchase	0	0	0	1,220	0	1,660	0	0	0
Debt Issued / Paid	-77	-517	241	3,750	-121	2,468	0	0	0
Other Financing Activities	-6	-32	-31	-16	-184	-4,162.9	847.5	-149.6	5,353
Financing Cash Flow	-83	-549	210	4,954	-305	-35.2	847.5	-149.6	5,353
Exchange Rate Effect	-12	-17	-31	27	-17	29	7.9	-26	-19.8
Net Cash Flow	7	-293	132	161	-333	354.1	64.6	-201.8	344.6
Free Cash Flow	131	281	324	-280	27	360.2	94.3	53	-73.2
Free Cash Flow Growth	-53.38%	-13.27%	-	-	-92.50%	281.97%	77.92%	-	-
Free Cash Flow Margin	2.97%	6.37%	6.80%	-8.56%	0.88%	11.75%	3.26%	1.82%	-2.52%
Free Cash Flow Per Share	0.27	0.57	0.67	-0.63	0.07	1.15	0.32	0.18	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).